- Home
- NNNN vs SONO Comparison
NNNN vs SONO Comparison
Compare NNNN & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- SONO
- Stock Information
- Founded
- NNNN 2021
- SONO 2002
- Country
- NNNN Germany
- SONO United States
- Employees
- NNNN N/A
- SONO N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SONO Consumer Electronics/Video Chains
- Sector
- NNNN Health Care
- SONO Consumer Discretionary
- Exchange
- NNNN Nasdaq
- SONO Nasdaq
- Market Cap
- NNNN 2.2B
- SONO 2.0B
- IPO Year
- NNNN 2025
- SONO 2018
- Fundamental
- Price
- NNNN $27.36
- SONO $16.28
- Analyst Decision
- NNNN
- SONO Strong Buy
- Analyst Count
- NNNN 0
- SONO 3
- Target Price
- NNNN N/A
- SONO $17.00
- AVG Volume (30 Days)
- NNNN 39.8K
- SONO 1.5M
- Earning Date
- NNNN 04-28-2026
- SONO 11-05-2025
- Dividend Yield
- NNNN N/A
- SONO N/A
- EPS Growth
- NNNN N/A
- SONO N/A
- EPS
- NNNN 0.06
- SONO N/A
- Revenue
- NNNN $8,185,146.00
- SONO $1,443,276,000.00
- Revenue This Year
- NNNN N/A
- SONO $2.89
- Revenue Next Year
- NNNN N/A
- SONO $8.55
- P/E Ratio
- NNNN $503.50
- SONO N/A
- Revenue Growth
- NNNN 21.95
- SONO N/A
- 52 Week Low
- NNNN $5.18
- SONO $7.63
- 52 Week High
- NNNN $55.65
- SONO $18.06
- Technical
- Relative Strength Index (RSI)
- NNNN 54.26
- SONO 46.70
- Support Level
- NNNN $12.93
- SONO $15.84
- Resistance Level
- NNNN $25.20
- SONO $17.37
- Average True Range (ATR)
- NNNN 4.99
- SONO 0.70
- MACD
- NNNN 1.61
- SONO -0.12
- Stochastic Oscillator
- NNNN 73.40
- SONO 20.24
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About SONO Sonos Inc.
Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa and the Asia Pacific. Generating a majority of its revenue from the Americas.